FI891357A0 - The method produces a salicylic acid-containing substance against scaly skin diseases - Google Patents

The method produces a salicylic acid-containing substance against scaly skin diseases

Info

Publication number
FI891357A0
FI891357A0 FI891357A FI891357A FI891357A0 FI 891357 A0 FI891357 A0 FI 891357A0 FI 891357 A FI891357 A FI 891357A FI 891357 A FI891357 A FI 891357A FI 891357 A0 FI891357 A0 FI 891357A0
Authority
FI
Finland
Prior art keywords
salicylic acid
skin diseases
containing substance
method produces
substance against
Prior art date
Application number
FI891357A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI891357A (en
FI94314C (en
FI94314B (en
Inventor
Konrad Minninger
David Tang
Rainer Oberhagemann
Original Assignee
Konrad Minninger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Konrad Minninger filed Critical Konrad Minninger
Publication of FI891357A publication Critical patent/FI891357A/en
Publication of FI891357A0 publication Critical patent/FI891357A0/en
Application granted granted Critical
Publication of FI94314B publication Critical patent/FI94314B/en
Publication of FI94314C publication Critical patent/FI94314C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)

Abstract

An agent containing salicylic acid for treating lepidosis in human and veterinary medicine contains 4 to 10 wt. % of salicylic acid, 1 to 7 wt. % of an aliphatic 1,2-diol, and 83 to 95 wt. % of a fatty oil, where the total weight of the agent = 100.
FI891357A 1987-07-25 1989-03-22 The method prepares a salicylic acid-containing substance against scaly skin diseases FI94314C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3724691A DE3724691C2 (en) 1987-07-25 1987-07-25 Pharmaceutical agent for the local therapy of flaking skin diseases
DE3724691 1987-07-25
PCT/EP1988/000649 WO1989000853A1 (en) 1987-07-25 1988-07-19 Agent containing salicylic acid for treating lepidosis
EP8800649 1988-07-19

Publications (4)

Publication Number Publication Date
FI891357A FI891357A (en) 1989-03-22
FI891357A0 true FI891357A0 (en) 1989-03-22
FI94314B FI94314B (en) 1995-05-15
FI94314C FI94314C (en) 1995-08-25

Family

ID=6332361

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891357A FI94314C (en) 1987-07-25 1989-03-22 The method prepares a salicylic acid-containing substance against scaly skin diseases

Country Status (9)

Country Link
EP (1) EP0325628B1 (en)
JP (1) JPH02500106A (en)
AT (1) ATE69550T1 (en)
AU (1) AU2072088A (en)
DE (2) DE3724691C2 (en)
DK (1) DK173547B1 (en)
FI (1) FI94314C (en)
NO (1) NO175885C (en)
WO (1) WO1989000853A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1001303B (en) * 1989-01-23 1993-07-30 Wolff Chem Pharm Gmbh Method for preparation of a means that contains salicyloxyd against scaling sick
WO1990008547A1 (en) * 1989-01-25 1990-08-09 Dr. August Wolff Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg Preparation containing salicylic acid for treating desquamative skin diseases
GB9223034D0 (en) * 1992-11-03 1992-12-16 Surtech Int Ltd Method and composition for prevention and/or treatment of dandruff and seborrhoeic dermatitis
SE9403541L (en) * 1994-10-14 1996-04-15 Sven Moberg Antimicrobial composition
US5736580A (en) * 1994-11-14 1998-04-07 Alza Croporation Composition, device, and method for electrotransport agent delivery
US5990179A (en) * 1995-04-28 1999-11-23 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US5985316A (en) * 1995-04-28 1999-11-16 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US6623724B2 (en) 1996-09-18 2003-09-23 Applied Genetics Incorporated Dermatics Dermatological compositions and methods
ES2245465T3 (en) * 1996-09-18 2006-01-01 Applied Genetics Incorporated Dermatics NORBORNENE AND NORBORNAN COMPOUND DIOLS FOR THE TREATMENT OF PIGMENTATION DISORDERS, NEURODEGENERATIVE DISEASES OR PROLIFERATIVE SKIN DISEASES.
DE10205193A1 (en) * 2002-02-08 2003-08-21 Beiersdorf Ag Cleaning preparations containing diol
DE10341179A1 (en) † 2003-09-06 2005-03-31 Beiersdorf Ag Cosmetic or dermatological preparations containing synergistic combination of alpha- or beta-hydroxyacid and alkanediol, useful for combating acne and/or Propionibacterium acnes infection
KR102009698B1 (en) 2011-12-20 2019-08-13 바이옴 테라퓨틱스 리미티드 Topical oil compositions for the treatment of fungal infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE762726C (en) * 1942-05-02 1952-09-15 Hydrierwerke A G Deutsche Solvent or solubilizer for salicylic acid
JPS57171912A (en) * 1981-04-14 1982-10-22 Sumitomo Chem Co Ltd Cream
FR2585575B1 (en) * 1985-08-01 1989-03-03 Pf Medicament PHARMACEUTICAL COMPOSITIONS WITH KERATOLYTIC ACTIVITY IN GEL FORM COMPRISING HYDROALCOHOLIC SALICYLIC ACID

Also Published As

Publication number Publication date
FI891357A (en) 1989-03-22
NO175885C (en) 1994-12-28
FI94314C (en) 1995-08-25
DE3724691A1 (en) 1989-02-02
ATE69550T1 (en) 1991-12-15
NO891220L (en) 1989-03-20
DE3724691C2 (en) 1999-03-18
FI94314B (en) 1995-05-15
DK137589D0 (en) 1989-03-21
EP0325628B1 (en) 1991-11-21
NO175885B (en) 1994-09-19
EP0325628A1 (en) 1989-08-02
AU2072088A (en) 1989-03-01
NO891220D0 (en) 1989-03-20
DE3866344D1 (en) 1992-01-02
WO1989000853A1 (en) 1989-02-09
DK137589A (en) 1989-05-19
JPH02500106A (en) 1990-01-18
DK173547B1 (en) 2001-02-19

Similar Documents

Publication Publication Date Title
EP0295331A3 (en) Use of vitamin e for normalizing the blood coagulation in the therapy with omega-3-type highly unsaturated fatty acids
SE9401406D0 (en) Pharmaceutical products for curing tumourous diseases and process for preparing same
EP0151989A3 (en) Means for the treatment of cardiac diseases
FI891357A0 (en) The method produces a salicylic acid-containing substance against scaly skin diseases
PT83474A (en) Therapeutic agents
ES478967A1 (en) 3,7-Disubstituted-3-cephem-4-carboxylic acid compounds
ATE51343T1 (en) RASHABLE TOPICAL PREPARATION FOR THERAPY OF PSORIASIS.
ZA784083B (en) Fatty acid and derivatives thereof,and formulations containing them for use in treatment or prophyllaxis of thrombo-embolic conditions
ES8205190A1 (en) 3,7,11,15-Tetramethyl- 2,4,6,10,14-hexadecapentaenoic Acid
DE3268159D1 (en) Medicaments based on algae, and formulations thereof
ES2006121A6 (en) Method for treating skin diseases
DE3373978D1 (en) Composition for the care or treatment of the human skin
GR3001793T3 (en) Polyprenyl alcohol-containing injections and use thereof
DE58904851D1 (en) SALICYL ACID CONTAINER AGAINST Dandruff Skin Diseases.
DE69129232D1 (en) ASPHODELUS COMPOSITION TO INCREASE THE NUMBER OF WHITE BLOOD CELLS
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
SE8800101D0 (en) APPLICATION OF ESSENTIAL FAT ACIDS FOR THE PREPARATION OF A PREPARATION FOR EXAMS TREATMENT
GR890100035A (en) Method for preparation of a means that contains salicyloxyd against scaling sick
IT1211765B (en) Water-soluble ubidecarenone derivs., and cosmetic compsns.
JPS54160666A (en) Medical agent to improve nutrition response in ruminant animal
SU1744810A1 (en) Vasoactive agent "dimephosphone" normalizing vegetative nervous system functions

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: MINNINGER, KONRAD

MA Patent expired